Clinical trial Recruiting at 1 site Interventional Ages 12 to 21

Non-invasive brain stimulation to improve language in people with Down syndrome.

Official title: Brain-directed Treatment to Improve Language in Adolescents and Young Adults With Down Syndrome: the Efficacy of Transcranial Direct Current Stimulation Coupled With Linguistic Training.

Run by Bambino Gesù Hospital and Research Institute · NCT07044804 · Data updated 2026-11-12

This project will test whether short sessions of transcranial direct current stimulation (tDCS) to the left frontal language area, combined with speech practice, can improve language in Italian-speaking adolescents and young adults with Down syndrome.

Quick facts

Study typeInterventional
Ages12 Years to 21 Years
SexAll
Enrollment36 (estimated)
SponsorBambino Gesù Hospital and Research Institute
Academic / other
Locations1 site (Rome)
StatusRecruiting
StartedJanuary 27, 2025
Main results expectedSeptember 30, 2026
Study endsSeptember 30, 2026
Registry record updatedJuly 24, 2026
Trial IDNCT07044804 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Italian-speaking adolescents and young adults (12–21 years) with confirmed free trisomy 21, mental age ≥ 4 years, measurable speech intelligibility (ICS ≥ 3.5), and low scores on naming subtests.

Probably not a fit

Those with epilepsy, major psychiatric disorders, significant hearing or vision deficits, very low naming or imitation ability, or inability to attend repeated in-person visits are unlikely to receive benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This proof-of-concept, double-blind, placebo-controlled trial applies transcranial direct current stimulation (tDCS) to the left inferior frontal gyrus (IFG)—using either anodal or cathodal protocols—combined with speech-language practice to try to improve naming and intelligibility in adolescents and young adults with Down syndrome. Participants are Italian-speaking individuals aged 12–21 with confirmed free trisomy 21 and defined speech and mental-age eligibility; they receive active or sham stimulation over multiple in-person sessions at a single pediatric research center. Outcome measures focus on standardized naming subtests and caregiver-rated speech intelligibility along with short-term maintenance assessments. The trial compares clinical change after combined tDCS-plus-training versus sham-plus-training to determine whether stimulation adds benefit to behavioral therapy.

Why it matters

Potential benefit: If successful, participants could have improved naming and speech intelligibility that persist beyond the training sessions.

How similar studies have gone: Previous small trials combining tDCS with cognitive or language training have reported modest benefits in adults and some pediatric samples, but applying cathodal protocols specifically in Down syndrome is largely novel and untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Italian speakers participants of both genders with the presence of a free trisomy 21 documented by karyotyping
2. Adolescents and young adults from 12 to 21 years old
3. Mental age ≥ 4 years (as assessed by Leiter-3 at baseline)
4. Scores \< 2 SD at the denomination subtest of BVL\_4-12
5. Be comprehensible to closest relatives, at least in part, exhibiting consistent speech sounds mesured by Intelligibility in Context Scale (ICS): Italian (McLeod, Harrison, \& McCormack, 2012) with a cut-off of 3.5
6. Informed consent/absent from each patient and Informed consent from their caregivers.

Exclusion Criteria:

1. The presence of any neurosensory deficits, such as hypoacusis or serious visual impairments
2. The presence of epilepsy, familiarity with epilepsy and major psychopathological disorders
3. Scores \< 10 points at the denomination subtest of BVL\_4-12
4. Ability to verbally imitate less that 7 of 10 words during an imitation screening task
5. Undergoing concomitant speech therapy or psychopharmacological therapy for cognitive or behavioral improvement.

Where it's running

  • Bambino Gesù Children's Hospital, IRCCS
    Rome, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.